Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.8.0.1
Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Revenue:    
Products, services, other $ 585,244 $ 525,998
Grant revenue 25,530 25,359
Total revenue 610,774 551,357
Costs and expenses:    
Cost of products and services 324,789 235,997
Research and development 324,976 263,456
Selling and marketing 274,468 213,009
General and administrative 794,605 837,998
Total operating costs and expenses 1,718,838 1,550,460
Operating loss (1,108,064) (999,103)
Other (expense) income:    
Interest expense, net (1,123,145) (1,240,373)
Other expense (959)
Impairment loss on investment (4,730) (6,069)
Gain on extinguishment of debt 4,285
Total other expense (1,123,590) (1,247,401)
Net loss $ (2,231,654) $ (2,246,504)
Net loss per share - basic and diluted $ (1.64) $ (2.16)
Weighted average common stock shares outstanding used in the basic and diluted net loss per share calculation 1,363,326 1,040,769